Eloxizumab is mainly used in the treatment of hyperlipidemia, especially for patients with elevated cholesterol is more effective. This drug, also known as PCSK9 inhibitor, has a more pronounced effect on cholesterol control. The main clinical indication is hypercholesterolemia, and it has a therapeutic effect on mixed hyperlipidemia, familial hypercholesterolemia, and it is especially suitable for patients who are intolerant to statin. Adverse reactions to the drug include allergic reactions, rash, abdominal pain, diarrhea, respiratory infections, etc. It is contraindicated in patients who are allergic to the components of the drug. PCSK9 inhibitors should be used under the guidance of a physician, master the indications, pay attention to the adverse reactions of the drug, and master the method of injection.